Project devoted to Cardiac regeneration by mRNA-triggered proliferation of cardiomyocytes (REGeRNA) founded within Horizon Europe has been launched. Project consortium structure:
Coordinator: Institut National de la Sante et de la Recherche Medicale
Participants: Academisch Ziekenhuis Leiden, Lipid Systems Ltd., Katholieke Universiteit Leuven, Inserm Transfert SA
Partners: Universitat Zurich
Lipid Systems as a commercial partner within the project consortium is responsible for the effective nano-carrier development and it’s GMP manufacturing for the Phase 1 clinical trial.
For more information please visit: